| Document |
Document Title |
|
WO/2022/149924A1 |
The purpose of the present invention is to provide: a crosslinked hyaluronic acid hydrogel in which a crosslinking agent and a polyol are used to reduce toxicity during crosslinking, and thereby enhance safety while increasing persistenc...
|
|
WO/2022/147743A1 |
Pharmaceutical compositions comprising a chemotherapeutic agent based on a β-substituted β-amino acid derivative are disclosed. The pharmaceutical compositions include a β-substituted β-amino acid derivative and a cyclodextrin deriva...
|
|
WO/2022/148836A1 |
The present invention relates to an encapsulated dye, comprising a dye, preferably a vat dye, and an encapsulating agent, preferably a cyclodextrin. The present invention further relates to a dye formulation for dyeing a fiber, a yarn co...
|
|
WO/2022/146749A1 |
The present disclosure pertains to iodinated polysaccharide compounds that comprise a polysaccharide backbone that comprises a plurality of carboxyl groups and a plurality of iodinated side groups. The present disclosure also pertains io...
|
|
WO/2022/142448A1 |
A preparation method for an exosome-loaded self-assembled polymer for use in oral colon-targeting drug delivery. The polymer is formed by compounding chitosan quaternary ammonium salt (HTCC), oxidized konjac glucomannan (OKGM), and a mes...
|
|
WO/2022/145885A1 |
The present invention relates to a method for producing a biomaterial for tissue repair, which significantly reduces the amount of a crosslinking agent used by means of a crosslinking reaction through a differentiated mixing and transfor...
|
|
WO/2022/136383A1 |
The invention relates to an in vitro storing and/or transporting of cells, comprising: - contacting the cells with an aqueous thermo-reversible gelling composition, in a liquid form and comprising: (A) a thermo-reversible gelling polysac...
|
|
WO/2022/138909A1 |
[Problem] The present invention provides: an equol clathrate having improved solubility in water; an equol-absorbent composition containing the equol clathrate; a production method for the clathrate; and an equol-absorbent composition co...
|
|
WO/2022/139115A1 |
The present invention is to increase production efficiency and decrease production cost. A method for preparation of alginic acid and fucoidan according to the present invention comprises the steps of: separating a mixture including grou...
|
|
WO/2022/130294A1 |
The invention relates to a prebiotic carbohydrate composition comprising POS and galacturonic acid from fruit peel that can be used as an ingredient for the formulation of food products. The prebiotic carbohydrate composition is useful a...
|
|
WO/2022/129317A1 |
The present invention relates to the use of a polymer of hyaluronic acid modified by the grafting thereto of at least one of the functions - SO3 and aromatic rings, as dopant for a polymer formed from one or monomers chosen from EDOT, Pr...
|
|
WO/2022/126261A1 |
The present application relates to fractions from a root portion of an American ginseng (Panax quinquefolius) plant, and in particular, an intermediate polysaccharide fraction, a neutral polysaccharide fraction, an acidic polysaccharide ...
|
|
WO/2022/125762A1 |
Methods for viscosupplementation in a joint or surgical site of a human or animal subject are disclosed along with unique materials for achieving such beneficial outcomes. The methods generally comprise introducing into the joint or surg...
|
|
WO/2022/124610A1 |
The present invention relates to a photocurable hemostatic composition and, specifically, to a photocurable liquid hemostatic composition containing a hyaluronic acid-based photocrosslinkable compound and a photoinitiator as active ingre...
|
|
WO/2022/121962A1 |
Disclosed in the present invention are a heteropoly oligosaccharide and an application thereof in improving plant disease resistance. The heteropoly oligosaccharide contains seven D-glucose residues and one D-galactose residue. Each hete...
|
|
WO/2022/117739A1 |
The present invention relates to storage-stable formulations of oligosaccharide preparations suitable for use in nutritional compositions such as animal feed.
|
|
WO/2022/117809A1 |
The present invention relates to a paper pulp comprising: - a mineral material content of at least 30% by weight; - a non-cellulosic polysaccharide content of at least 10% by weight; and - a cellulosic polysaccharide content of at least ...
|
|
WO/2022/116385A1 |
The present disclosure relates to the technical field of biomedical materials, and relates to unsaturated hydroxybutyl chitosan and a thermosensitive hydrogel, and a preparation method therefor and the use thereof. Provided are unsaturat...
|
|
WO/2022/118163A1 |
Disclosed are soluble polyelectrolyte complexes of polymeric biguanidine antimicrobial, such as polyhexamethylene biguanide or polyaminopropyl biguanide, with glycosaminoglycans, such as hyaluronic acid, chondroitin or chondroitin sulpha...
|
|
WO/2022/112944A1 |
The invention relates to a nanosystem for the diagnosis, image-guided treatment of tumors and monitoring of the tumor microenvironment. The nanosystem is a contrast agent comprising a polymer shell based on a hyaluronic acid nanogel, sup...
|
|
WO/2022/113940A1 |
The present invention provides a polyrotaxane which is represented by formula (1). (In the formula, R1 represents a hydrogen atom or a methyl group; m represents a number from 1 to 2,000; n represents a number from 10 to 500; formula (2)...
|
|
WO/2022/107108A1 |
The present disclosure relates to an ink comprising a gellan gum, unmodified or modified with divinyl sulfone; and a peptide sequence containing a cysteine, wherein the peptide is linked to the gellan gum via the divinyl sulfone moieties.
|
|
WO/2022/107013A1 |
The present invention relates to a process for the synthesis of Fondaparinux pentasaccharide and its intermediates. Specifically, the present invention relates to a novel catalytic process for the synthesis of Fondaparinux pentasaccharid...
|
|
WO/2022/106676A1 |
The invention relates to beads and a composition comprising an aqueous phase comprising a plurality of beads, the beads comprising or consisting of a hydrogel matrix comprising at least one carboxyalkyl chitosan having glucosamine units,...
|
|
WO/2022/101551A1 |
A method for preparing esterified cellulose and/or hemicellulose is disclosed. The method may comprise mixing an anhydride mixture and cellulose and/or hemicellulose, thereby obtaining an esterification mixture, such that the anhydride m...
|
|
WO/2022/090734A1 |
The invention relates to an isolated polysaccharide and a composition comprising the polysaccharide for use in treating a neurodegenerative disease.
|
|
WO/2022/084852A1 |
The present invention relates to methods for purifying bacterial polysaccharides, in particular for removing impurities from cellular lysates of bacteria producing polysaccharides.
|
|
WO/2022/086978A1 |
Plant-sourced lipid and inulin crumble pieces are prepared by providing an inulin gel composition; providing a plant-sourced lipid composition in liquid form; mixing the plant-sourced lipid composition in liquid form with the inulin gel ...
|
|
WO/2022/078612A1 |
The present invention relates to a method for releasing glycostructures from glycoproteins or enveloped viruses comprising glycostructures on their envelopes. Further, the invention relates to a method for isolating glycostructures from ...
|
|
WO/2022/011040A9 |
CD dimers, CD compositions, and uses thereof are disclosed herein. CD dimers, and compositions thereof, that may be useful for various purposes including the targeting of 7KC. The design and testing of CD dimers are described herein. Exe...
|
|
WO/2022/077853A1 |
The present invention relates to a method for extracting grifola frondosa active polysaccharide on the basis of a membrane filtration technology, and grifola frondosa active polysaccharide extracted by the method and a use thereof. The m...
|
|
WO/2022/071624A1 |
The present invention provides a self-assembled supramolecular hyaluronic acid hydrogel. The self-assembled supramolecular hyaluronic acid hydrogel according to the present invention enables mechanical strength to be controlled according...
|
|
WO/2022/071841A1 |
The invention relates to dextran sulfate, or a pharmaceutically acceptable salt thereof, for use in improving liver function in a subject suffering from a non-alcoholic fatty liver disease (NAFLD). The dextran sulfate, or the pharmaceuti...
|
|
WO/2022/067774A1 |
A preparation method of a sea cucumber polysaccharide, comprising the following steps: (1) taking dry sea cucumbers, pulverizing the dry sea cucumbers into coarse particles, adding water to conduct enzymatic hydrolysis, performing centri...
|
|
WO/2022/069620A1 |
The present invention relates to a method for producing a low-ester, high-calcium-reactive-pectin and to a low-ester, high-calcium-reactive pectin obtainable by said method. The invention further relates to the use of the low-ester pecti...
|
|
WO/2022/068629A1 |
A production method for accurately controlling the molecular weight and esterification degree of small molecular pectin by an enzyme-alkali combination method. The method comprises: first cracking the molecular weight of pectin to a targ...
|
|
WO/2022/068927A1 |
A low molecular heparin-polypeptide-crosslinked cyclodextrin organic skeleton (LMW H-polypeptide-COF) composition with lung targeting and a preparation method therefor. Also disclosed are a drug-carrying LMWH-polypeptide-COF composition ...
|
|
WO/2022/062380A1 |
The present invention discloses a Tibetan Ganoderma lucidum polysaccharide GLP-1 with an antioxidant effect, a preparation method and the use. The Ganoderma lucidum polysaccharide GLP-1 is extracted from Tibetan Ganoderma lucidum powder,...
|
|
WO/2022/062101A1 |
Provided is the use of a swim-bladder-derived heparin mucopolysaccharide in the preparation of an angiogenesis inhibitor, which use relates to the technical field of medicine. The swim-bladder-derived heparin mucopolysaccharide has the s...
|
|
WO/2022/066958A1 |
The present disclosure is related to processes for efficient large-scale preparation of alkylated cyclodextrins. The processes of the present disclosure provide high purity alkylated cyclodextrins with high purity and low levels of chlor...
|
|
WO/2022/061419A1 |
The present invention provides a method for providing a food grade thickener, the method comprising the steps of: establishing an aqueous continuous phase of a first polysaccharide, adding a second polysaccharide to the continuous phase ...
|
|
WO/2022/064272A1 |
A liquid material including a polysaccharide is manufactured by creating a mixture of polysaccharides and an aqueous solvent or an aqueous cosolvent with organic solvents at a temperature at which gelation does not occur. The mixture is ...
|
|
WO/2022/067188A1 |
A composition comprising an oat derived, salt precipitated β-(1,3)-(1,4) glucan having a molecular weight from about 150 kDa to about 250 kDa, a Mw/Mn ratio of about 1.0 to about 1.25, and a D3/D4 ratio of about 1.5 to less than about 2.0.
|
|
WO/2022/063312A1 |
The present invention discloses a hyaluronic acid hydrogel and a hyaluronic acid film, a preparation method therefor, and applications thereof. In the present invention, a hyaluronic acid derivative M and a hyaluronic acid derivative F a...
|
|
WO/2022/065382A1 |
An oil repellent agent capable of imparting satisfactory oil repellency is provided using a natural material that is a biomass material in harmony with the environment. The oil repellent agent has a structure such that a hydrogen atom in...
|
|
WO/2022/064240A1 |
The present invention provides a juglone/ß-cyclodextrin inclusion complex, a formulation containing same, and a drug having this formulation, preferably in the form of an ointment or a gel. Alternatively, by the present invention provid...
|
|
WO/2022/065843A1 |
The present invention provides: a super absorbent polymer exhibiting excellent biodegradability without degradation of properties, of the super absorbent polymer, such as water retention and absorbency under load; and a preparation metho...
|
|
WO/2022/062011A1 |
Provided is a method for purifying low-molecular weight fucosylated glycosaminoglycan by means of tangential flow ultrafiltration. The method comprises the following steps: (1) dissolving a crude product in a certain proportion of water,...
|
|
WO/2022/058809A1 |
The present invention relates to a porous, adherent and biocompatible multilayer polymer matrix which enables the growth of adherent and suspended cells and an active control of mobilisation and fixation of active compounds. The polymer ...
|
|
WO/2022/056998A1 |
A simple and green preparation method for acid modified cyclodextrin, relating to the field of modified cyclodextrin. Cyclodextrin and succinic acid are mutually modified in a catalyst condition by means of an esterification reaction, an...
|
